Anterogen Co., Ltd.
Clinical trials sponsored by Anterogen Co., Ltd., explained in plain language.
-
Can stem cells seal Crohn's fistulas? new trial aims to find out
Disease control OngoingThis phase 3 study tests whether a patient's own fat-derived stem cells, combined with fibrin glue, can close fistulas caused by Crohn's disease. About 46 adults with Crohn's and at least one fistula will receive either the stem cell mixture or fibrin glue alone. The main goal is…
Phase: PHASE3 • Sponsor: Anterogen Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New knee osteoarthritis treatment shows early promise in small trial
Symptom relief OngoingThis early-stage study tested a new treatment called ANT-301 in 6 people with severe knee osteoarthritis. The main goal was to check if the treatment is safe and to see if it helps reduce pain and improve knee function. The study is now complete and results are being analyzed.
Phase: PHASE1 • Sponsor: Anterogen Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 11:59 UTC